Related Experiment Videos
Serum beta-2 microglobulin as a marker of B-cell activation in chronic lymphoid malignancies
American Journal of Hematology
|October 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Acute steroid myopathy: a highly overlooked entity.
QJM : monthly journal of the Association of Physicians·2018
Cured Multiple Myeloma Followed by Primary Malignant Lymphoma of the Lung.
Leukemia & lymphoma·2016
Chronic Lymphocytic Leukemia in Young Adults: Report of Six Cases Under the Age of 30 Years.
Leukemia & lymphoma·2016
Tumor Necrosis Factor Production in B Cell Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Splenic Tropism and Spleen-Modulated Systemic Inflammation in Acute Plasmodium vivax Malaria.
American journal of hematology·2026
The Presence and Percentage of Circulating Nucleated Red Blood Cells Reveal Distinct Characteristics in Adults With Sickle Cell Disease.
American journal of hematology·2026
Anticoagulant Therapy and Bleeding-Related Hospitalizations in Patients With Cancer: A National Cohort Study.
American journal of hematology·2026
Primary Plasma Cell Leukemia.
American journal of hematology·2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.
American journal of hematology·2026
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026
Netrin-1 suppresses CCL2-driven macrophage migration: implications for modulating vascular inflammation and aortic sinus enlargement in hyperlipidaemic mice.
Journal of molecular and cellular cardiology plus·2026